Gkegkes I D, Iavazzo C
First Department of Surgery, General Hospital of Attica "KAT", Athens, Greece.
Acta Chir Belg. 2015 May-Jun;115(3):212-8. doi: 10.1080/00015458.2015.11681099.
The concept of sentinel lymph node (SLN) is not new to medical practice especially in breast cancer patients. CEU microbubble technique is an innovative technique which is applied with the same purpose. It utilizes ultrasound contrast agents based on the use of dispersion with sulfur hexafluoride gas. The aim of this review is to examine the clinical evidence on the role of intradermally injected microbubbles as a technique of preoperative identification of SLNs in patients with breast cancer.
A systematic search was performed in PubMed (5 October 2014), Scopus (5 October 2014) and Cochrane libraries (5 October 2014).
Five prospective studies were included in the study. The total number of patients included was 727. The age of the included patients ranged from 19 to 93 years old. The median diameter of tumor ranged from 2 to 120 mm. Regarding the histological type, ductal carcinoma in situ was present in 31 patients, invasive ductal carcinoma in 438, invasive lobular carcinoma in 71 and not defined invasive breast tumors in 52 patients. The SLN identification rate ranged from 9.3% to 55.2% and the sensitivity from 61% to 89% while the false negative rate from 6.6% to 39% and the presence of micro/macrometastases from 1.9% to 64.3%.
CEU microbubble technique is an alternative technique of SLN detection in breast cancer patients. Further studies are necessary to standardize the method and clarify its specificity and sensitivity. Moreover, randomized control trials are suggested in order to compare this technique with the current techniques used for SLN detection.
前哨淋巴结(SLN)的概念在医学实践中并不新鲜,尤其是在乳腺癌患者中。CEU微泡技术是一种应用目的相同的创新技术。它基于六氟化硫气体分散体使用超声造影剂。本综述的目的是研究皮内注射微泡作为乳腺癌患者术前识别SLN技术的临床证据。
在PubMed(2014年10月5日)、Scopus(2014年10月5日)和Cochrane图书馆(2014年10月5日)进行了系统检索。
该研究纳入了五项前瞻性研究。纳入患者总数为727例。纳入患者年龄范围为19至93岁。肿瘤中位直径范围为2至120毫米。关于组织学类型,31例患者为原位导管癌,438例为浸润性导管癌,71例为浸润性小叶癌,52例患者为未明确的浸润性乳腺肿瘤。SLN识别率范围为9.3%至55.2%,敏感性为61%至89%,假阴性率为6.6%至39%,微/大转移灶的存在率为1.9%至64.3%。
CEU微泡技术是乳腺癌患者SLN检测的一种替代技术。需要进一步研究来规范该方法并阐明其特异性和敏感性。此外,建议进行随机对照试验,以便将该技术与目前用于SLN检测的技术进行比较。